Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
about
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
description
scientific article published on 02 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Androgen receptor degradation ...... rostate cancer drug resistance
@en
Androgen receptor degradation ...... rostate cancer drug resistance
@nl
type
label
Androgen receptor degradation ...... rostate cancer drug resistance
@en
Androgen receptor degradation ...... rostate cancer drug resistance
@nl
prefLabel
Androgen receptor degradation ...... rostate cancer drug resistance
@en
Androgen receptor degradation ...... rostate cancer drug resistance
@nl
P2093
P2860
P1476
Androgen receptor degradation ...... rostate cancer drug resistance
@en
P2093
Andrew P Crew
Donald P McDonnell
Hanqing Dong
Meizhong Jin
Nick J Vitale
Ryan R Willard
Shanique Alabi
Taavi K Neklesa
P2860
P356
10.1038/S42003-018-0105-8
P407
P577
2018-08-02T00:00:00Z